KLRK1 and glioblastoma: In conclusion, this study demonstrated that VPA treatment increased NKG2D ligands expression via the PI3K/Akt signaling pathway in glioblastoma cells, making glioblastoma cells more susceptible to NKG2D CAR-T cell-mediated cytotoxicity in vitro and in vivo.